HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 247 filers reported holding HAEMONETICS CORP in Q4 2017. The put-call ratio across all filers is 1.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,105,000 | -57.0% | 36,246 | -66.7% | 0.03% | -62.1% |
| Q3 2017 | $4,890,000 | -29.9% | 108,976 | -38.3% | 0.09% | -41.6% |
| Q2 2017 | $6,979,000 | +18.4% | 176,719 | +21.6% | 0.15% | +14.6% |
| Q1 2017 | $5,895,000 | +995.7% | 145,318 | +984.5% | 0.13% | +712.5% |
| Q4 2016 | $538,000 | -3.6% | 13,400 | -13.1% | 0.02% | -23.8% |
| Q3 2016 | $558,000 | -62.9% | 15,419 | -70.3% | 0.02% | -74.1% |
| Q2 2016 | $1,503,000 | +491.7% | 51,853 | +614.6% | 0.08% | +406.2% |
| Q1 2016 | $254,000 | -74.5% | 7,256 | -76.5% | 0.02% | -79.2% |
| Q4 2015 | $995,000 | +141.5% | 30,860 | +142.1% | 0.08% | +18.5% |
| Q3 2015 | $412,000 | +6.2% | 12,747 | +36.0% | 0.06% | +333.3% |
| Q2 2015 | $388,000 | +36.6% | 9,376 | +48.2% | 0.02% | +36.4% |
| Q1 2015 | $284,000 | +35.9% | 6,327 | +13.1% | 0.01% | 0.0% |
| Q4 2014 | $209,000 | -16.7% | 5,596 | -22.1% | 0.01% | -42.1% |
| Q3 2014 | $251,000 | – | 7,188 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
| HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
| Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
| Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
| ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
| Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
| Dean Capital Management | 15,309 | $812,000 | 0.70% |
| Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |